Medtronic Wins FDA Clearance for LigaSure RAS Maryland on Hugo Robot
Article excerpt
Medtronic announced on September 16, 2026, that the U.S. Food and Drug Administration (FDA) has cleared the LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery (RAS) system. The clearance expands the instrument lineup available on the Hugo system for U.S. robotic-assisted procedures. According to Medtronic, the LigaSure RAS Maryland is built to work only with the Valleylab FT10 energy platform on the Hugo RAS system. The company said the instrument seals and cuts vessels, thick tissue, and lymphatics up to and including 7 mm in diameter, and that it seals vessels in approximately 2 seconds while limiting thermal spread to surrounding tissue. Medtronic describes the LigaSure RAS Maryland as the first robotically driven LigaSure instrument, and said the vessel-sealing technology it incorporates has been used in more than 45 million procedures across more than 65 countries over the past two decades. The instrument was introduced on the Hugo RAS system in Europe in 2025 following CE Mark. Medtronic’s product page for the device states that the jaw vessel sealer has reached the U.S. market, and describes it as pairing ValleyLab FT10 generator sealing with the versatility of the Hugo RAS system. The Hugo RAS system is cleared in the U.S. for urologic surgical procedures and, according to the company, is in commercial use at a growing number of health...
Keep reading with a free account
The rest of this article, and every signal for Medtronic, is in your free account.
Extracted from this sentence
In a June 3, 2026 announcement , Medtronic said it had submitted 510(k) filings to the FDA seeking clearance for Hugo system use in general surgery, including hernia repair, and in gynecologic surgery.
